Great News 2017-05-08 16:16 ET - News Release
Mr. Ash Kaushal reports
CHROMEDX COMPLETES RECEPTOR COMPONENT AND COMMENCES PACKAGING OF HEMOPALM ANALYZER PROTOTYPE
ChroMedX Corp. has completed the cartridge receptor component for the HemoPalm analyzer prototype. The company also announces the engagement of rapid prototyping firm Agile Manufacturing Inc. to complete the final assembly and packaging of the HemoPalm Analyzer prototype.
The receptor is a crucial part of the HemoPalm analyzer responsible for receiving, aligning and activating the measurement process of the cartridge. This was the final component required to complete prototype assembly, and ChroMedX is now working with Agile Manufacturing to package the functional prototype.
"We are very excited to move into the assembly and packaging phase following the completion of the cartridge receptor. Agile's rapid prototyping capabilities make them an ideal partner in this final stage of prototype development," said Ash Kaushal, president and chief executive officer of ChroMedX.
The HemoPalm prototype is now being assembled and packaged conjointly with Canada's largest 3-D printing service company, Agile Manufacturing, of Uxbridge, Ont. Agile is currently refining the assembly of the prototype and designing the housing for the hand-held prototype.
Receptor function
The receptor includes the following components:
- A front opening to receive and align the cartridge and thereby provide electrical contact between the biosensors and the analyzer;
- A mechanism for activating the calibration blister and air bladder;
- A light source to pass through the blood in the optical chamber for measurement in the spectrometer;
- Heating elements on the surface of the bottom portion of the receptor to preheat the blood;
- A thermistor for regulating the heaters;
- A spring-loaded ball mechanism to hold the cartridge against the heaters and to keep it in operational position.
The measurement process will start automatically once correct cartridge insertion is detected and will progress through the following steps:
- Optical reading will be performed for the CO-oximeter measurement.
- The built-in mechanism will activate and rupture the blister, releasing calibration fluid into the biosensor chamber in order to calibrate the sensors.
- A second built-in mechanism will activate the air bladder, pushing the blood sample into the biosensor chamber. An air bubble created in the cartridge will keep the blood and calibration fluid separate during this stage, with the air bubble assisting in purging the calibration fluid out of the biosensor chamber.
- With blood now occupying the biosensor chamber, measurements by the biosensors will be performed and results displayed on the HemoPalm LCD.
With regard to the foregoing, the company recently announced the filing of second PCT (Patent Cooperation Treaty) application on its patented HemoPalm hand-held blood analyzer, accounting for continued innovations and potentially extending protection on the intellectual property to 2037.
About ChroMedX Corp.
ChroMedX is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing.
The HemoPalm hand-held blood analyzer system is the only hand-held blood analysis technology which combines blood gases and electrolytes with full CO-oximetry.
We seek Safe Harbor.